Search | Result
| ID | 1177 |
|---|---|
| Class | Mammalia |
| Species | Homo sapiens |
| Tissue | Blood |
| Sample | Blood |
| Disease type | Breast Cancer |
| Cell type | B cells |
| Cell type (subtype) | B cells |
| Cell marker | CD19, MS4A1 |
| Frequency | |
| PubMed ID | 32822091 |
| Journal | Mol Carcinog |
| SCI IF | 3.7 |
| Evidence | For PBMCs, these markers included:CD7, CD3D, IL7R, and CD8a in T cells; CD19 and MS4A1 in B cells; CD207 indendritic cells (DCs); IL3RA in plasmacytoid dendritic cells (pDCs);CD33 and CD14 in CD14 + monocytes; CD33 and FCGR3A (CD16) in CD16 + monocytes; NCAM1 in natural killer cells; ITGA2B, ITGB3, SELP, and PF4 in megakaryocytes (MKs)/platelets |
| Title | Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells |
| Authors | Heather M. Brechbuhl et al. |
| Date | 2020.7 |
| Data available | GSE139495 |
